Harvard Bioscience Inc reports results for the quarter ended in September 30 - Earnings Summary

Harvard Bioscience

07/11/2024 20:45

* Harvard Bioscience Inc  HBIO.OQ  reported a quarterly
adjusted
loss of 2 cents​​ per share for the quarter ended September 30,
lower than the same quarter last year, when the company reported
EPS of 1 cents.  The mean expectation of three analysts for the
quarter was for earnings of 3 cents per share. Wall Street
expected results to range from zero cents to 5 cents per share.
    * Revenue fell 13.4% to $21.97 million from a year ago;
analysts
expected $25.30 million. 
    * Harvard Bioscience Inc's reported EPS for the quarter was
a loss
of 11 cents​.
    * The company reported a quarterly loss of $4.8 million.
    * Harvard Bioscience Inc shares had risen by 4.8% this
quarter and
lost 47.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 46.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Harvard
Bioscience Inc is $6.25 
This summary was machine generated from LSEG data November 7 at
08:44 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jan. 1 0001       0.03           -0.02          Missed
 Jun. 30 2024      0.05           0.00           Missed
 Mar. 31 2024      0.02           0.02           Met
 Dec. 31 2023      0.05           0.04           Missed